A Phase I Study Evaluating the Integration of Hypofractionated Renal Ablative Radiation Therapy in the Setting of Metastatic Renal Cell Carcinoma
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society